Education
About Us
Working with TipRanks
Follow Us
ANI Pharmaceuticals Inc (ANIP)
NASDAQ:ANIP
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 614.38M | $ 486.82M | $ 316.38M | $ 216.14M | $ 208.47M |
| Gross Profit | $ 364.17M | $ 305.30M | $ 177.60M | $ 115.53M | $ 121.32M |
| Operating Income | $ 584.00K | $ 46.97M | $ -35.28M | $ -39.79M | $ -16.02M |
| EBITDA | $ 63.12M | $ 106.60M | $ 25.04M | $ 3.12M | $ 28.13M |
| Net Income | $ -18.52M | $ 18.78M | $ -47.90M | $ -42.60M | $ -22.55M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 151.17M | $ 221.12M | $ 48.23M | $ 100.30M | $ 7.86M |
| Total Assets | $ 1.28B | $ 904.42M | $ 760.09M | $ 771.60M | $ 461.19M |
| Total Debt | $ 624.09M | $ 285.67M | $ 286.52M | $ 287.37M | $ 185.69M |
| Net Debt | $ 479.23M | $ 64.55M | $ 238.29M | $ 187.07M | $ 177.82M |
| Total Liabilities | $ 855.17M | $ 446.82M | $ 421.55M | $ 412.86M | $ 265.49M |
| Stockholders' Equity | $ 428.53M | $ 457.60M | $ 338.54M | $ 358.74M | $ 195.70M |
| Cash Flow | |||||
| Free Cash Flow | $ 47.06M | $ 100.45M | $ -47.66M | $ -20.32M | $ -53.05M |
| Operating Cash Flow | $ 64.02M | $ 118.96M | $ -31.20M | $ 3.32M | $ 15.27M |
| Investing Cash Flow | $ -404.72M | $ -18.51M | $ -15.74M | $ -105.48M | $ -68.32M |
| Financing Cash Flow | $ 264.94M | $ 67.44M | $ -5.13M | $ 194.59M | $ -1.44M |